Company Overview of Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc., a biopharmaceutical company, develops vaccine adjuvant therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and enhance the effectiveness of vaccines. Coley Pharmaceutical Group, Inc. was formerly known as CpG ImmunoPharmaceuticals, Inc. and changed its name to Coley Pharmaceutical Group, Inc in August 2000. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
93 Worcester Street
Wellesley, MA 02481
Founded in 1997
Key Executives for Coley Pharmaceutical Group, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact Coley Pharmaceutical Group, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.